πŸ‡ΊπŸ‡Έ FDA
Patent

US 12383587

AAV triple-plasmid system

granted A61KA61K35/761A61K38/17

Quick answer

US patent 12383587 (AAV triple-plasmid system) held by Takeda Pharmaceutical Company Limited expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K35/761, A61K38/17